Cell Kinetics: A prognostic marker in epithelial ovarian cancer

Redman, 1986, Prognostic factors in advanced ovarian carcinoma, J. Clin. Oncol., 4, 515, 10.1200/JCO.1986.4.4.515 Rodenburg, 1987, Tumor ploidy as a major prognostic factor in advanced ovarian cancer, Cancer, 59, 317, 10.1002/1097-0142(19870115)59:2<317::AID-CNCR2820590225>3.0.CO;2-4 Richardson, 1985, Common epithelial cancer of the ovary, N. Engl. J. Med., 312, 415, 10.1056/NEJM198502143120706 Ozols, 1984, Chemotherapy of ovarian cancer, Semin. Oncol., 11, 251 Klein, 1985, Advanced ovarian carcinoma, Cancer, 55, 1829, 10.1002/1097-0142(19850415)55:8<1829::AID-CNCR2820550831>3.0.CO;2-C Dembo, 1982, Choice of postoperative therapy based on prognostic factors, Int. J. Radiat. Oncol. Biol. Phys., 8, 893, 10.1016/0360-3016(82)90096-7 Griffiths, 1975, Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma, Natl. Cancer Inst. Monogr., 42, 101 Bolis, 1987, Randomized comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer, Lancet, 8555, 353 Malkasian, 1975, Histology of epithelial tumors of the ovary: Clinical usefulness and prognostic significance of the histologic classification and grading, Semin. Oncol., 2, 191 Ozols, 1980, Advanced ovarian cancer. Correlation of histologic grade with response to therapy and survival, Cancer, 45, 572, 10.1002/1097-0142(19800201)45:3<572::AID-CNCR2820450325>3.0.CO;2-3 Friedlander, 1984, Influence of cellular DNA content on survival in advanced ovarian cancer, Cancer Res., 44, 397 Frankfurt, 1984, Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors, Cytometry, 5, 71, 10.1002/cyto.990050111 Volm, 1985, Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma, Cancer Res., 45, 5180 Erba, 1985, DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies, Brit. J. Cancer, 52, 565, 10.1038/bjc.1985.228 Iversen, 1987, Ploidy assessment of benign and malignant ovarian tumors by flow cytometry, Cancer, 60, 82, 10.1002/1097-0142(19870701)60:1<82::AID-CNCR2820600114>3.0.CO;2-D Paradiso, 1986, Cell kinetics of human epithelial ovarian cancers, Bas. Appl. Histochem., 30, 215 Conte, 1987, Tumor cell kinetics: A new prognostic factor Daidone, 1987, Cell kinetics in ovarian cancers Costa, 1981, Labeling index as a prognostic marker in non-Hodgkin lymphomas, J. Natl. Cancer Inst., 66, 1 Durie, 1980, Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma, Blood, 55, 364, 10.1182/blood.V55.3.364.364 Elequin, 1978, Correlation between in vitro labeling indices (LIs) and tumor regression following radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 4, 207, 10.1016/0360-3016(78)90139-6 Silvestrini, 1985, Cell kinetics as a prognostic marker in node-negative breast cancer, Cancer, 56, 78, 10.1002/1097-0142(19851015)56:8<1982::AID-CNCR2820560816>3.0.CO;2-I Costa, 1987, Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skin, Cancer, 60, 2797, 10.1002/1097-0142(19871201)60:11<2797::AID-CNCR2820601133>3.0.CO;2-B Pecorelli, 1988, Randomized comparison of cisplatin (P) and carboplatin (C) in advanced ovarian cancer Costa, 1983, Relationship between cell kinetics of primary tumor and lymph node metastases of the same patient Silvestrini, 1987, Cell kinetics as a prognostic marker in locally advanced breast cancer, Cancer Treat. Rep., 71, 375